# A Prospective Study of Monitoring Immune Response in Locally Advanced Cervix Cancer

> **NCT03559803** · NA · UNKNOWN · sponsor: **Sichuan University** · enrollment: 58 (actual)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT03559803
- **Lead sponsor:** Sichuan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2019-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03559803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03559803, "A Prospective Study of Monitoring Immune Response in Locally Advanced Cervix Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03559803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*